Self‐Enhancing Drug Pair‐Driven Selenium Nanotherapeutics Reverses Microglial Pyroptosis Through NLRP3/Caspase‐1 Pathway and Neuronal Apoptosis for Treatment of Spinal Cord Injury DOI Open Access

Jinggong Liu,

Luo-Qi Mai,

Aaron C. Tan

et al.

Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown

Published: March 23, 2025

Abstract Spinal cord injury (SCI) constitutes a critical occurrence that results in the disruption of both motor and sensory functions. Oxidative stress‐induced apoptosis pyroptosis have been identified as contributors to neuronal damage during secondary phase following SCI. Therefore, this study focuses on development self‐enhancing drug pair‐driven selenium (Se) nanotherapeutics, loading with 2,3,5,6‐tetramethylpyrazine (TMP) Ginsenoside Rg1 (Rg1), enhance treatment The engineered LET/TMP/Rg1@Se NPs exhibits remarkable antioxidant properties, effectively reducing oxidative by minimizing reactive oxygen species (ROS) accumulation restoring mitochondrial function. In addition their effects, nanotherapeutics demonstrates significant anti‐pyroptotic effects BV2 microglial cells modulating NLRP3/caspase‐1 pathway, leading decreased release pro‐inflammatory cytokines IL‐1β IL‐18. Moreover, inhibition inflammatory cascade response diminishes neuroinflammation‐induced promotes axonal regeneration neurons vitro. mouse model SCI, improved function regeneration, attributed pyroptosis, highlighting scientific basis for synergistic effect Se an innovative strategy effective SCI therapy.

Language: Английский

Application and mechanism of cell therapy technology in the repair of spinal cord injury: a narrative review DOI
Fanzhuo Zeng, Hua Fu, Yang Liu

et al.

Advanced technology in neuroscience ., Journal Year: 2025, Volume and Issue: 2(1), P. 16 - 26

Published: Feb. 6, 2025

Spinal cord injury is a severe traumatic disorder of the central nervous system. Cell therapy one primary treatment options for spinal injury, and it has been shown to have substantial effect on treatment. However, mechanisms underlying cell transplantation remain poorly understood. The transition from fundamental research clinical application impeded by unresolved mechanistic uncertainties, ethical safety concerns, outdated methodologies. Herein, we summarize which aids in recovery highlight recent advances relevant methodologies technologies, address challenges faced translation. A better understanding these overcoming hurdles translating into practice are crucial hold considerable promise advancing field.

Language: Английский

Citations

0

Augmenting rehabilitation robotics with spinal cord neuromodulation: A proof of concept DOI
Nicolas Hankov, Miroslav Caban, Robin Demesmaeker

et al.

Science Robotics, Journal Year: 2025, Volume and Issue: 10(100)

Published: March 12, 2025

Rehabilitation robotics aims to promote activity-dependent reorganization of the nervous system. However, people with paralysis cannot generate sufficient activity during robot-assisted rehabilitation and, consequently, do not benefit from these therapies. Here, we developed an implantable spinal cord neuroprosthesis operating in a closed loop robust walking and cycling assisted by robotic devices. This is device agnostic designed for seamless implementation nonexpert users. Preliminary evaluations participants showed that enabled well-organized patterns muscle cycling. A proof-of-concept study suggested augmented promoted sustained neurological improvements. Moreover, recreational activities outdoors. Future clinical trials will have confirm findings broader population.

Language: Английский

Citations

0

Succinic acid-based biodegradable hydrogels drive Bv2 microglial polarization by ATP metabolism DOI
Jingwen Zhao, Yongqiang Xiong, Xinying Wang

et al.

Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112383 - 112383

Published: March 1, 2025

Language: Английский

Citations

0

The diversity and plasticity of descending motor pathways rewired after stroke and trauma in rodents DOI Creative Commons
Takahiro Inoue, Masaki Ueno

Frontiers in Neural Circuits, Journal Year: 2025, Volume and Issue: 19

Published: March 21, 2025

Descending neural pathways to the spinal cord plays vital roles in motor control. They are often damaged by brain injuries such as stroke and trauma, which lead severe impairments. Due limited capacity for regeneration of circuits adult central nervous system, currently no essential treatments available complete recovery. Notably, accumulating evidence shows that residual descending dynamically reorganized after injury contribute Furthermore, recent technological advances cell-type classification manipulation have highlighted structural functional diversity these pathways. Here, we focus on three major pathways, namely, corticospinal tract from cerebral cortex, rubrospinal red nucleus, reticulospinal reticular formation, summarize current knowledge their structures functions, especially rodent models (mice rats). We then review discuss process patterns reorganization induced following injury, compensate lost connections Understanding basic properties each pathway principles induction outcome rewired will provide therapeutic insights enhance interactive rewiring multiple

Language: Английский

Citations

0

Self‐Enhancing Drug Pair‐Driven Selenium Nanotherapeutics Reverses Microglial Pyroptosis Through NLRP3/Caspase‐1 Pathway and Neuronal Apoptosis for Treatment of Spinal Cord Injury DOI Open Access

Jinggong Liu,

Luo-Qi Mai,

Aaron C. Tan

et al.

Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown

Published: March 23, 2025

Abstract Spinal cord injury (SCI) constitutes a critical occurrence that results in the disruption of both motor and sensory functions. Oxidative stress‐induced apoptosis pyroptosis have been identified as contributors to neuronal damage during secondary phase following SCI. Therefore, this study focuses on development self‐enhancing drug pair‐driven selenium (Se) nanotherapeutics, loading with 2,3,5,6‐tetramethylpyrazine (TMP) Ginsenoside Rg1 (Rg1), enhance treatment The engineered LET/TMP/Rg1@Se NPs exhibits remarkable antioxidant properties, effectively reducing oxidative by minimizing reactive oxygen species (ROS) accumulation restoring mitochondrial function. In addition their effects, nanotherapeutics demonstrates significant anti‐pyroptotic effects BV2 microglial cells modulating NLRP3/caspase‐1 pathway, leading decreased release pro‐inflammatory cytokines IL‐1β IL‐18. Moreover, inhibition inflammatory cascade response diminishes neuroinflammation‐induced promotes axonal regeneration neurons vitro. mouse model SCI, improved function regeneration, attributed pyroptosis, highlighting scientific basis for synergistic effect Se an innovative strategy effective SCI therapy.

Language: Английский

Citations

0